This was confirmed by the use of the natural agonist of mGluR1 (glutamate) which was correlated with an increase in cell viability in melanoma cells but failed to stimulate phosphoinositide (PI) hydrolysis, indicating that the activation of mGluR1 did not follow the canonical PLC/PI signaling in melanoma. The gene discussed is HSPG2; the disease is melanoma.